Cargando…
Clinical Management of Risk of Radiation Pneumonia with Serum Markers During the Radiotherapy for Patients with Thoracic Malignant Tumors
PURPOSE: Risk of radiation pneumonia (RP) could not be effectively detected due to non-specific clinical symptoms in the early stage. The purpose of this investigation was to evaluate serum biomarkers of cytokines interleukin-6 (IL-6), C-reactive protein (CRP) and procalcitonin (PCT) for its early d...
Autores principales: | Deng, Yuxia, Qiu, Ting, Patel, Nishant, Zhou, Shi, Xue, Tao, Zhang, Haijun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6901038/ https://www.ncbi.nlm.nih.gov/pubmed/31824195 http://dx.doi.org/10.2147/CMAR.S231995 |
Ejemplares similares
-
A simple-to-use nomogram for predicting the risk of radiation pneumonitis in patients with thoracic segment esophageal squamous cell carcinoma
por: Qiu, Ting, et al.
Publicado: (2022) -
The Predictive Value of MLR for Radiation Pneumonia During Radiotherapy of Thoracic Tumor Patients
por: Gao, Ya, et al.
Publicado: (2020) -
Radiotherapy in thoracic malignancies: the preface
por: Jassem, Jacek, et al.
Publicado: (2021) -
Developments in radiation techniques for thoracic malignancies
por: Finazzi, Tobias, et al.
Publicado: (2021) -
Improved survival with higher radiation dose for esophageal squamous cell carcinoma patients treated with definitive chemoradiotherapy
por: Deng, Yuxia, et al.
Publicado: (2017)